HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2
- PMID: 15078991
HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2
Abstract
We previously showed that HIV-1 protease inhibitors slowed the proliferation of human myeloid leukemia cells and enhanced their differentiation in the presence of all-trans retinoic acid (ATRA). In this study, we found that protease inhibitors, including ritonavir, saquinavir, and nelfinavir, but not indinavir, induced growth arrest and apoptosis of U266, RPMI8226, and ARH77 human multiple myeloma (MM) cells in association with down-regulation of antiapoptotic protein Mcl-1. Also, protease inhibitors inhibited the survival of freshly isolated MM cells from patients. In contrast, these protease inhibitors did not affect survival of normal B cells and colony formation of myeloid committed stem cells (CFU-GM) from healthy volunteers. In addition, we found that all of the protease inhibitors, except for indinavir, blocked interleukin-6 (IL-6)-stimulated phosphorylation of both signal transducer and activator of transcription 3 (STAT 3) and extracellular signal-regulated kinase 1/2 in U266 and RPMI8226 MM cells. Moreover, the protease inhibitors inhibited both the basal and IL-6-stimulated STAT 3/DNA binding activity in U266 cells as measured by an ELISA-based assay. Furthermore, ritonavir inhibited production of vascular endothelial growth factor one of the targets of STAT 3, in U266 and RPMI8226 cells as measured by ELISA. Taken together, protease inhibitors might be useful for treatment of individuals with MM.
Similar articles
-
JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.Br J Haematol. 2000 Jun;109(4):823-8. doi: 10.1046/j.1365-2141.2000.02127.x. Br J Haematol. 2000. PMID: 10929036
-
Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling.Oncol Rep. 2009 Aug;22(2):377-83. Oncol Rep. 2009. PMID: 19578780
-
HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling.Cancer Sci. 2005 Jul;96(7):425-33. doi: 10.1111/j.1349-7006.2005.00063.x. Cancer Sci. 2005. PMID: 16053514 Free PMC article.
-
Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6.Blood. 2002 Mar 15;99(6):2172-8. doi: 10.1182/blood.v99.6.2172. Blood. 2002. PMID: 11877294
-
Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.Leuk Lymphoma. 2003 Sep;44(9):1477-81. doi: 10.3109/10428190309178767. Leuk Lymphoma. 2003. PMID: 14565647 Review.
Cited by
-
Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance.Blood Cancer J. 2013 Mar 1;3(3):e103. doi: 10.1038/bcj.2013.2. Blood Cancer J. 2013. PMID: 23454896 Free PMC article.
-
New drugs are not enough‑drug repositioning in oncology: An update.Int J Oncol. 2020 Mar;56(3):651-684. doi: 10.3892/ijo.2020.4966. Epub 2020 Jan 20. Int J Oncol. 2020. PMID: 32124955 Free PMC article. Review.
-
The HIV protease inhibitor ritonavir synergizes with butyrate for induction of apoptotic cell death and mediates expression of heme oxygenase-1 in DLD-1 colon carcinoma cells.Br J Pharmacol. 2004 Dec;143(7):890-8. doi: 10.1038/sj.bjp.0706023. Epub 2004 Oct 25. Br J Pharmacol. 2004. PMID: 15504750 Free PMC article.
-
Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models.Cancers (Basel). 2023 Aug 2;15(15):3939. doi: 10.3390/cancers15153939. Cancers (Basel). 2023. PMID: 37568755 Free PMC article.
-
Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma.Cancer Res. 2021 Sep 1;81(17):4581-4593. doi: 10.1158/0008-5472.CAN-20-3323. Epub 2021 Jun 22. Cancer Res. 2021. PMID: 34158378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous